Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes.

Alexandra Sawyer¹, Emma G Wilmot^2,3, Duy Do⁴, Kellee M Miller⁴, Trang T Ly⁴, Gregory P Forlenza¹

¹Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

²School of Medicine, University of Nottingham, Nottingham, UK.

³Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Trust, Royal Derby Hospital, Derby, UK.

⁴Insulet Corporation, Acton, Massachusetts, USA.

PubMed DOI

Abstract

OBJECTIVE: Identifying programmable device settings and user behaviors associated with achieving glycemic targets is critical for informing clinical practice and improving outcomes with automated insulin delivery (AID) systems. This real-world analysis aimed to identify predictors of achieving optimal glycemic outcomes for people with type 1 diabetes (T1D) using the Omnipod® 5 AID System. METHODS…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.